NCT05879029View on ClinicalTrials.gov

Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD

PHASE4RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Laryngopharyngeal Reflux
Interventions
DRUG

Jinsang Liyan Capsule; Rabeprazole enteric-coated tablets.

Participants in the experimental group were given Jinsang Liyan Capsule + Rabeprazole enteric-coated tablets according to the requirements, and were followed up at 4 and 8 weeks. VAS and RSI scores were used to judge the improvement degree of patients' symptoms.

DRUG

Jinsang Liyan Capsule placebo; Rabeprazole enteric-coated tablets.

Participants in the control group were given Jinsang Liyan Capsule placebo + Rabeprazole enteric-coated tablets according to the requirements, and were followed up at 4 and 8 weeks. VAS and RSI scores were used to judge the improvement degree of patients' symptoms.

Trial Locations (1)

Unknown

RECRUITING

Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
collaborator

Xi'an Beilin Pharmaceutical Co. Ltd

UNKNOWN

lead

Tongji Hospital

OTHER